SFTRAK-M-INJECTION
About SFTRAK-M-INJECTION
SFTRAK-M-INJECTION is a pharmaceutical product manufactured and marketed by A3A Pharmaceutical Pvt Ltd, a WHO-GMP compliant company based in Patna, Bihar, India. It contains Meropenem Injection, and forms part of our Surgeon range.
Therapeutic segment: Surgeon.
Product information
- Composition
- Meropenem Injection
- Uses
- Severe gram-negative infections
- Recommended dosage
- 1 vial IV
Frequently asked questions
What is SFTRAK-M-INJECTION?
SFTRAK-M-INJECTION is a pharmaceutical product containing Meropenem Injection, manufactured and marketed by A3A Pharmaceutical Pvt Ltd, Patna, Bihar, India.
What is SFTRAK-M-INJECTION used for?
As per the product information, SFTRAK-M-INJECTION is indicated for Severe gram-negative infections. Use only as directed by a qualified healthcare professional.
What is the composition of SFTRAK-M-INJECTION?
SFTRAK-M-INJECTION contains Meropenem Injection.
What is the recommended dosage of SFTRAK-M-INJECTION?
1 vial IV Always follow the dosage prescribed by your doctor.
Which therapeutic segment does SFTRAK-M-INJECTION belong to?
SFTRAK-M-INJECTION is part of the Surgeon range of A3A Pharmaceutical Pvt Ltd.
Who manufactures SFTRAK-M-INJECTION?
SFTRAK-M-INJECTION is manufactured and marketed by A3A Pharmaceutical Pvt Ltd, a WHO-GMP compliant pharmaceutical company based in Patna, Bihar, India. For distribution, PCD franchise or bulk supply enquiries call +91-83404-30743.
Enquiry
For distribution, PCD franchise or bulk supply enquiries about SFTRAK-M-INJECTION, contact A3A Pharmaceutical Pvt Ltd on +91-83404-30743 or email a3apharma@gmail.com.